B · Normal
On September 21, Oppenheimer lowered the target price of Boston Scientific from US$85 to US$65.
Related telegraphs
[Analyst: The moat of personal intelligence far exceeds that of chatbots. OpenAI
09-22 17:56
[Coherent launches integrated optical platform for AI infrastructure and is expe
09-22 17:21
[Well-known investor: The S&P 500 is expected to first rise above 8,000 points b
09-22 17:16
[All three major U.S. stock index futures turned higher] On September 22, the Do
09-22 16:55
On September 22, Swiss sports brand Angpa’s U.S. stocks rose about 5% before the
09-22 16:49
September 22nd, Amazon’s Low Earth Orbit Project (LEO) is expected to begin init
09-22 16:37
Comments